Philipson Tomas Jan 4

What Happened
Philipson Tomas Jan, a director of Jupiter Neurosciences, received a grant of 536,428 stock options (derivative securities) on June 29, 2026. The report shows an acquisition at $0.00 (grant of options); these options give the right to purchase one share each but do not represent immediately owned common shares or a cash purchase.

Key Details

• Transaction date: 2026-06-29; Transaction type: Award/Grant (code A); reported filing date: 2026-07-01. No late filing indicated in the information provided.
• Quantity: 536,428 stock options (each option = right to purchase one share). Reported acquisition price: $0.00 (grant). The option exercise/strike price is not specified in the excerpt.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: F1 — 90,000 options granted for appointment to the board; 446,428 options granted in lieu of cash compensation (annual board retainer and committee fees).
• Vesting: Options vest in 12 equal quarterly installments beginning September 2, 2026, contingent on continued service as a director through each vesting date.

Context
This was an option grant (compensation), not a purchase or sale of common stock. Option grants are a routine form of director pay and don’t mean shares were sold or exercised. Because vesting is phased over three years (quarterly), the economic benefit is realized gradually and only if the director remains in service.